XTalks

SEPTEMBER 23, 2020

Being hailed as the world’s shortest and thinnest needle for insulin injection, Droplet Micron has recently been introduced into the pen needle market by HTL (High Tech Lab)-STREFA, Inc. These are important feature innovations for those that depend on insulin injections. The new and innovative needle measures at just 34G x 3.5mm.

Insulin 98

Insulin Marketing Drug Delivery Compliance 98

Camargo

OCTOBER 14, 2020

Approval of the Month: FDA Approves First Closed-Loop Monitoring and Drug Delivery Device. The FDA has announced its approval of a bluetooth-controlled insulin delivery and monitoring system for use in pediatric patients ages 2 through 6 with Type 1 diabetes. Senior Director of Regulatory Compliance and Submissions.

Development 196

Development Insulin Drug Delivery Production 196

XTalks

FEBRUARY 24, 2021

The injection experience is an often-overlooked aspect in insulin administration. For many daily insulin users, the experience is an important one, as it is directly related to quality of life and medication compliance. Related: Droplet Micron Insulin Needle Offers Innovation in Crowded Diabetes Supply Market.

Insulin 64

Insulin Production Drug Delivery Marketing 64

Roots Analysis

SEPTEMBER 18, 2023

Therefore, medical technology is rapidly evolving, enabling more advanced and patient-friendly methods of drug delivery. In the pursuit of creating patient-centric healthcare solutions, the medical industry has witnessed a groundbreaking advancement in drug delivery with the emergence of large volume wearable injectors.

Drug Delivery 52

Drug Delivery Drugs Compliance Marketing 52

Roots Analysis

FEBRUARY 22, 2022

Autoinjector As Emerging Drug Delivery Device. The field is presently witnessing several innovations, such as LED / LCD-based visualization, Bluetooth connectivity, dosage recording, safety lock, visual / audible drug delivery confirmation notifications, and automatic drug reconstitution.

Drug Delivery 52

Drug Delivery Production Marketing Development 52

FDA Law Blog

JANUARY 5, 2023

Claud — As we turn into the New Year, we offer a few items of interest in digital and telehealth regulation, enforcement, and compliance that may provide some helpful guideposts for stakeholders. One example is the Warning Letter FDA sent to Medtronic in late 2021 concerning a vulnerability in insulin infusion pumps. By John W.M.

Regulation 59

Regulation Production Drug Delivery Marketing 59

Roots Analysis

SEPTEMBER 22, 2023

These innovative instruments combine precision, convenience, and patient-centered design to revolutionize drug delivery. These devices are equipped with advanced features like programmable dosing, connectivity to mobile apps, and safety mechanisms to ensure accurate and controlled drug delivery.

Drug Delivery 40

Drug Delivery Marketing Insulin Drugs 40